Device Trial Radar · NCT04817267
Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings
Last checked: Nov 19, 2026Latest source record: May 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
8
Actual
Start
Mar 11, 2022
Primary completion
Jan 1, 2023
Study completion May 1, 2024
Sponsor
- Lead sponsor
- Johns Hopkins UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Pear Therapeutics, Inc.
- First posted
- Mar 26, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized controlled pilot study will evaluate feasibility, acceptability, and potential efficacy of an app, reSET-O, for patients being started on buprenorphine in acute care settings.
Conditions
- Opioid-use Disorder
Interventions
reSET-O appDevice
The reSET-O app, a prescription digital therapeutic, provides cognitive behavioral therapy for opioid use disorder. The app provides psychoeducation related to opioid use, coping skills, and skills to avoid relapse.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of approached patients who are eligible for and interested in participationTime frame: 3 months
- Acceptability as assessed by the Treatment Acceptability QuestionnaireTime frame: 3 months
- Acceptability as assessed by the System Usability ScaleTime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Johns Hopkins Bayivew Emergency Department
Baltimore, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.